Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / July / From Variants to Voices Rethinking Success in Genomic Medicine
Bioinformatics Point of care testing Precision medicine Profession Training and education Opinion and Personal Narratives Professional Development Molecular Pathology Voices in the Community

From Variants to Voices: Rethinking Success in Genomic Medicine

"We found the variant, but now what?" asks Dina Abdelhakam

By Dina Abdelhakam 07/07/2026 Opinion 4 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Poll
  • Top Institutions

Share

Clinical Report: From Variants to Voices: Rethinking Success in Genomic Medicine

Background

Genomic medicine has advanced significantly over the past two decades, with improvements in sequencing technologies and diagnostic yields. However, the focus has often been on technical success rather than the implications of genetic diagnoses for patients and families. Understanding the journey following a diagnosis is crucial for effective patient care and decision-making.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

  • Genetic diagnoses are often seen as endpoints, but they initiate a longer journey for families.
  • Patients frequently face uncertainties and decisions that are not addressed by the technical report alone.
  • Laboratories prioritize turnaround time and diagnostic yield, but these metrics do not reflect patient understanding or follow-up.
  • As genomic medicine evolves, the responsibility of healthcare providers includes ensuring that patients comprehend their results and implications.
  • Communication and education are essential components of genomic care, not just technical performance.

Clinical Implications

Healthcare professionals must enhance their communication skills to effectively convey genomic information to patients and families.

Conclusion

The integration of scientific progress with patient experience is vital in genomic medicine.

Related Resources & Content

  1. Obesity and Endocrinology, Oxford Academic, 2023 -- Genetic variant reclassification: a narrative review
  2. The Medicine Maker, 2026 -- Scaling Genomics for Precision Medicine
  3. The ASCO Post, 2013 -- Integrating Genomic Sequencing Into Clinical Care
  4. ACMG, 2025 -- Policy Statements
  5. The ASCO Post — National Cancer Policy Summit: Setting Priorities for the Next 3 Years
  6. ACMG issues new guidance on reporting variants of uncertain significance in genetic and genomic testing
  7. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update
  8. Ethical Considerations for Genetic Testing and Counseling in Obstetrics and Gynecology | ACOG
  9. Policy Statements
  10. The Clinical Pharmacogenetics Implementation Consortium’s consensus-based framework for assigning allele function - PMC
  11. Read "Exploring Clinical Guidelines for the Adoption of Genomic Testing: Proceedings of a Workshop—in Brief" at NAP.edu
  12. NHS England » NHS Genomic Medicine Service: Whole Genome Sequencing
  13. Evaluation | Genomics England
  14. Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial | Nature Medicine
  15. Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial | Intensive Care Medicine | Springer Nature Link
  16. Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial - PubMed
  17. The Effect of Metagenomic Sequencing on Patient Clinical Outcomes for Intraocular Infections: A Multicenter Randomized Controlled Trial - ScienceDirect
  18. Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study - ScienceDirect
  19. The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments - ScienceDirect
  20. A Randomized Hybrid‐Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx‐ACT) Trial - Smith - 2025 - Clinical and Translational Science - Wiley Online Library
  21. Pharmacogenomic-guided opioid therapy for pain: a systematic review and meta-analysis of randomised controlled trials | The Pharmacogenomics Journal
  22. Germline Genetic Variant Classification Requires More Equitable Reference Database Representation | Pediatrics | American Academy of Pediatrics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Dina Abdelhakam

Dina Abdelhakam is Assistant Professor and Consultant Clinical Pathologist at Faculty of Medicine, Ain Shams University, Egypt

More Articles by Dina Abdelhakam

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

What’s New in Infectious Disease? (December 2021)
Point of care testing
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Resisting Resistance
Point of care testing
Resisting Resistance

October 21, 2016

1 min read

Rapid, affordable tests to spot bacterial infections could reduce antibiotic overprescription in resource-limited settings

HIV/AIDS: A Shifting Epidemic
Point of care testing
HIV/AIDS: A Shifting Epidemic

April 4, 2022

1 min read

HIV diagnoses in heterosexual people in the UK have overtaken those in gay and bisexual men

Career Snapshots with Bamidele Farinre
Point of care testing
Career Snapshots with Bamidele Farinre

April 20, 2022

3 min read

Michael Schubert interviews Bamidele Farinre about her work in mobile laboratory testing

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.